Arvinas - Public Comps and Valuation Multiples

Arvinas Overview

About Arvinas

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Founded

2013

HQ

Employees

430

Website

arvinas.com

Sectors

Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $273M

LTM EBITDA -$99.3M

EV

-$181M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Arvinas Financials

As of September 2025, Arvinas reported last 12-month revenue of $273M and EBITDA of -$99.3M.

In the same period, Arvinas generated $273M in LTM gross profit and -$102M in net income.

See Arvinas valuation multiples based on analyst estimates

Arvinas P&L

In the most recent fiscal year, Arvinas reported revenue of $263M and EBITDA of -$244M.

Arvinas expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Arvinas valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$273M	XXX	$263M	XXX	XXX	XXX
Gross Profit	$273M	XXX	n/a	XXX	XXX	XXX
Gross Margin	100%	XXX	n/a	XXX	XXX	XXX
EBITDA	-$99.3M	XXX	-$244M	XXX	XXX	XXX
EBITDA Margin	-36%	XXX	-92%	XXX	XXX	XXX
EBIT	-$144M	XXX	-$250M	XXX	XXX	XXX
EBIT Margin	-53%	XXX	-95%	XXX	XXX	XXX
Net Profit	-$102M	XXX	-$199M	XXX	XXX	XXX
Net Margin	-37%	XXX	-76%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Arvinas including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $273M. EBITDA for the last twelve months was -$99.3M. In the most recent fiscal year, Arvinas achieved $263M in revenue and -$244M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$273M	Analyst estimates available to subscribers	$263M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$273M	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	100.0% gross margin	Analyst estimates available to subscribers	NaN% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$99.3M	Analyst estimates available to subscribers	-$244M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-36.4% EBITDA margin	Analyst estimates available to subscribers	-92.5% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$144M	Analyst estimates available to subscribers	-$250M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-52.8% EBIT margin	Analyst estimates available to subscribers	-95.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$102M	Analyst estimates available to subscribers	-$199M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-37.5% net profit margin	Analyst estimates available to subscribers	-75.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Arvinas

This financial data table provides comprehensive performance metrics for Arvinas, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Arvinas generated $273M in revenue over the last twelve months.
The company achieved -$99.3M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $273M.
Net income over the last twelve months reached -$102M.

Fiscal Year Performance

In the most recent fiscal year, Arvinas reported $263M in total revenue.
Fiscal year EBITDA was -$244M.
The company maintained a gross profit margin of NaN% in the most recent fiscal year.
EBITDA margin for the fiscal year was -92.5%.
Net profit margin reached -75.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Arvinas. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Arvinas Stock Performance

Arvinas has current market cap of $670M, and EV of -$181M.

Market Cap Evolution

Arvinas Stock Data

As of October 2, 2025, Arvinas's stock price is $9.

See Arvinas trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
-$181M	$670M	XXX	XXX	XXX	XXX	$-1.42

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Arvinas Valuation Multiples

Arvinas's trades at -0.7x EV/Revenue multiple, and 0.7x EV/EBITDA.

See valuation multiples for Arvinas and 15K+ public comps

Arvinas Financial Valuation Multiples

As of October 2, 2025, Arvinas has market cap of $670M and EV of -$181M.

Equity research analysts estimate Arvinas's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Arvinas has a P/E ratio of -6.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$670M	XXX	$670M	XXX	XXX	XXX
EV (current)	-$181M	XXX	-$181M	XXX	XXX	XXX
EV/Revenue	-0.7x	XXX	-0.7x	XXX	XXX	XXX
EV/EBITDA	1.8x	XXX	0.7x	XXX	XXX	XXX
EV/EBIT	1.3x	XXX	0.7x	XXX	XXX	XXX
EV/Gross Profit	-0.7x	XXX	n/a	XXX	XXX	XXX
P/E	-6.6x	XXX	-3.4x	XXX	XXX	XXX
EV/FCF	n/a	XXX	0.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Arvinas Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Arvinas Margins & Growth Rates

Arvinas's last 12 month revenue growth is -39%

Arvinas's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $1.2M for the same period.

Arvinas's rule of 40 is -542% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Arvinas's rule of X is -133% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Arvinas and other 15K+ public comps

Arvinas Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	-39%	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	-36%	XXX	-92%	XXX	XXX	XXX
EBITDA Growth	9%	XXX	-62%	XXX	XXX	XXX
Rule of 40	-542%	XXX	-131%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-133%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.6M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$1.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	132%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	195%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial